NO20032079L - Fremgangsmåte for fremstilling av 4-(17<alfa>-metyl- substituerte-3-oksoöstra-4,9-dien-11<beta>-yl)benzaldehyd-(1E eller 1Z)-oksimer - Google Patents

Fremgangsmåte for fremstilling av 4-(17<alfa>-metyl- substituerte-3-oksoöstra-4,9-dien-11<beta>-yl)benzaldehyd-(1E eller 1Z)-oksimer

Info

Publication number
NO20032079L
NO20032079L NO20032079A NO20032079A NO20032079L NO 20032079 L NO20032079 L NO 20032079L NO 20032079 A NO20032079 A NO 20032079A NO 20032079 A NO20032079 A NO 20032079A NO 20032079 L NO20032079 L NO 20032079L
Authority
NO
Norway
Prior art keywords
sub
group
radical
alkyl
alkyl group
Prior art date
Application number
NO20032079A
Other languages
English (en)
Other versions
NO20032079D0 (no
NO325338B1 (no
Inventor
Gerd Schubert
Sven Ring
Bernd Erhart
Gerd Mueller
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20032079L publication Critical patent/NO20032079L/no
Publication of NO20032079D0 publication Critical patent/NO20032079D0/no
Publication of NO325338B1 publication Critical patent/NO325338B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0085—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0015—Oxiranes at position 9(11)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20032079A 2000-11-10 2003-05-09 Fremgangsmate for fremstilling av 4-(17<alfa>-metyl-substituerte-3-oksoostra-4,9-dien-11<beta>-yl)benzaldehyd-(1E eller 1Z)-oksimer, samt forbindelser fremstilt ved fremgangsmaten NO325338B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10056675A DE10056675A1 (de) 2000-11-10 2000-11-10 Verfahren zur Herstellung von 4-(17alpha-Methylsubstituierten 3-Oxoestra-4,9-dien-11ß-yl)-benzaldehyd-(1E oder 1Z)-oximen
PCT/DE2001/004217 WO2002038581A2 (de) 2000-11-10 2001-11-09 Verfahren zur herstellung von 4-(17alpha-substituierten-methyl) 3-oxoestra-4,9-dien-11beta-yl)benzaldehyd-(1e oder 1z)-oximen

Publications (3)

Publication Number Publication Date
NO20032079L true NO20032079L (no) 2003-05-09
NO20032079D0 NO20032079D0 (no) 2003-05-09
NO325338B1 NO325338B1 (no) 2008-03-31

Family

ID=7663440

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032079A NO325338B1 (no) 2000-11-10 2003-05-09 Fremgangsmate for fremstilling av 4-(17<alfa>-metyl-substituerte-3-oksoostra-4,9-dien-11<beta>-yl)benzaldehyd-(1E eller 1Z)-oksimer, samt forbindelser fremstilt ved fremgangsmaten

Country Status (9)

Country Link
US (1) US7268241B2 (no)
EP (1) EP1339733B1 (no)
JP (1) JP4331478B2 (no)
AT (1) ATE404579T1 (no)
AU (1) AU2002216910A1 (no)
DE (2) DE10056675A1 (no)
ES (1) ES2311559T3 (no)
NO (1) NO325338B1 (no)
WO (1) WO2002038581A2 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090054387A1 (en) 2006-04-18 2009-02-26 Detlef Grawe Method for preparing 4-[17beta-methoxy-17alpha-methoxymethyl-3-oxestra-4,9-dien-11beta-yl]benzaldehyde (E)-oxime (asoprisnil)
DE102006018888A1 (de) * 2006-04-18 2007-10-25 Bayer Schering Pharma Ag Verfahren zur Herstellung von 4-[17beta-Methoxy-17alpha-methoxymethyl-3-oxoestra-4,9-dien-11beta-yl]benzaldehyd-(E)-oxims (Asoprisnil)
CN119490551B (zh) * 2024-11-15 2025-10-31 湖北葛店人福药业有限责任公司 一种地屈孕酮的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE289539C (no) *
DD289539A5 (de) * 1989-10-12 1991-05-02 Zi F. Mikrobiologie U. Experimentelle Therapie,De Verfahren zur herstellung von 11 beta-(4-acetylphenyl)-17alpha-alkoxy-methyl-estra-4,9-dien-3-onen
DE4332283A1 (de) * 1993-09-20 1995-04-13 Jenapharm Gmbh Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
JP4331478B2 (ja) 2009-09-16
US7268241B2 (en) 2007-09-11
WO2002038581A2 (de) 2002-05-16
US20040063172A1 (en) 2004-04-01
ES2311559T3 (es) 2009-02-16
EP1339733A2 (de) 2003-09-03
WO2002038581A3 (de) 2002-09-12
JP2004513178A (ja) 2004-04-30
NO20032079D0 (no) 2003-05-09
DE10056675A1 (de) 2002-05-16
NO325338B1 (no) 2008-03-31
EP1339733B1 (de) 2008-08-13
DE50114228D1 (de) 2008-09-25
ATE404579T1 (de) 2008-08-15
AU2002216910A1 (en) 2002-05-21

Similar Documents

Publication Publication Date Title
DE3270307D1 (en) Succinimide derivates and process for preparation thereof
BG105457A (en) Method for the preparation of citalopram
AU562802B2 (en) Preparation of phosphorus-containing cyanohydrins
NO20032079L (no) Fremgangsmåte for fremstilling av 4-(17&lt;alfa&gt;-metyl- substituerte-3-oksoöstra-4,9-dien-11&lt;beta&gt;-yl)benzaldehyd-(1E eller 1Z)-oksimer
DK400781A (da) Fremgangsmaade til fremstilling af 2-(1,4-benzodioxan-2-ylalkyl) imidazoler
IL175940A0 (en) Prostaglandin synthesis
DE69015831D1 (de) Selektive Veretherung.
JO2433B1 (en) Preparation of heterocyclic lindane landscapes
FI20030026A0 (fi) Menetelmä substituoitujen imidatsolijohdannaisten valmistamiseksi ja menetelmässä käytettäviä välituotteita
AU2003264895A1 (en) Process for the preparation of fluorohaloalkanes
ES8105998A1 (es) Un procedimiento para la produccion de nuevos derivados de 6-alquil-7-fenil-1,6-naftiridin-5(6h)-ona y sus sales de adi-cion de acidos.
DK112082A (da) Fremgangsmaade til fremstilling af polyalkylindaner
NO20032080D0 (no) Fremgangsmåte for fremstilling av 4-(17&lt;alfa&gt;-substituerte-3- oksoöstra-4,9-dien-11-yl)benzaldehyd-(1E eller 1Z)-oksimer
PL364879A1 (en) Process to prepare aryltriazolinones and novel intermediates thereto
YU62302A (sh) Postupak za izradu jedinjenja 2-(4-alkil-1-piperazinil)- benzaldehida i benzilidenila
ES485801A1 (es) Un procedimiento de preparacion de ciclo-1,3,2-oxazafosfo- ril-derivados
ATE17710T1 (de) Keten-0,0-acetale und verfahren zu ihrer herstellung.
JPS5759856A (en) Benzene derivative
NO20014530D0 (no) Fremgangsmåte for fremstilling av 4, 4-dimetyl-3&lt;beta&gt;- hydroksy-pregna-8, 14-dien-21-karboksylsyreestere ogmellomprodukter ved fremgangsmåten
SE8303565D0 (sv) Process for the preparation of 1-alkyl- or 1,4-dialkyl-1h-pyrrole-2-acetic acid esters
JPS56108758A (en) Sulfonate derivative and its preparation
JPS5589284A (en) Preparation of xanthine derivative
JPS5753463A (en) Omega-aminoalkoxyphenylpyarazole and its acid addition salt
JPS5661364A (en) Dihydroxyphthalazinone derivative and its preparation

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees